A Martin Lerner

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Source: treatmentcenterforcfs.com

Dr. A. Martin Lerner, aka Martin Lerner, (d. 2015) was a much beloved and respected Myalgic Encephalomyelitis/Chronic Fatigue Syndrome specialist who died in October 2015, at the age of 86.[1]

He was one of the experts on the "Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" that was convened for the 2015 Institute of Medicine report,[2] as well as, one of the authors of the 2003 Canadian Consensus Criteria for Myalgic Encephalomyelitis, published as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome:Clinical Working Case Definition,Diagnostic and Treatment Protocols[3]

He was a strong advocate of using antivirals because he hypothesized CFS is caused by 3 herpesviruses: Epstein-Barr virus, cytomegalovirus and/or Human herpesvirus 6. "These three viruses establish “latent” infection in B-lymphocytes, monocyte-macrophage precursors, or T-lymphocytes respectively. Virus reactivation, and both abortive and complete virus multiplication occur. Therefore CFS patients have been described with continuing primary or reactivated infections.[4]

Notable studies in ME/CFS[edit | edit source]

Talks and interviews[edit | edit source]

Talks on Lerner's webpage[edit | edit source]

  • August 22, 2007 – Dr. A Martin Lerner presenting Medical Grand Rounds at William Beaumont Hospital in Royal Oak, MI on the Topic of Chronic Fatigue Syndrome. - (Video)
  • May 23, 2008 – Dr. A Martin Lerner’s presentation on The Sub-grouping & Treatment for ME/CFS, at the 3rd annual Invest in ME International ME/CFS Conference in London, England. - (Video)
  • October 12, 2010 – Dr. A Martin Lerner’s presentation on Successful Antiviral Treatment of CFS and Its Science at the CFSAC biannual meeting hosted by the Department of Health and Human Services in Washington, DC. - (Video)
  • August 20, 2011, Part 1 – Dr. A Martin Lerner presenting at William Beaumont Hospital in Royal Oak, MI to infectious disease physicians in Michigan "A Primer on ME/CFS -Background, Virology, Immunology, Pathologic Physiology, Diagnosis and Treatment." - (Video); PDF Download of presentation slides; PDF Download of ME/CFS Treatment Resource Guide for Practitioners
  • August 20, 2011, Part 2 – Dr. A Martin Lerner presenting at William Beaumont Hospital in Royal Oak, MI to infectious disease physicians in Michigan "A Primer on ME/CFS -Background, Virology, Immunology, Pathologic Physiology, Diagnosis and Treatment."- (Video); PDF Download of presentation slides; PDF Download of ME/CFS Treatment Resource Guide for Practitioners

Invest in ME International ME Conference[edit | edit source]

  • 2008, Speaker at the 3rd Invest in ME International ME Conference on Diagnosis and Treatment of ME/CFS - Longitudinal Observations of Cardiac and Antiviral studies[7] - (Video)

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. http://www.irakaufman.com/mobile/detail.php?id=5990
  2. Syndrome, Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue; Populations, Board on the Health of Select; Medicine, Institute of (February 10, 2015). Biographical Sketches of Committee Members, Consultants, and Staff. National Academies Press (US).
  3. http://phoenixrising.me/wp-content/uploads/Canadian-definition.pdf
  4. "http://treatmentcenterforcfs.com/personal_statement/index.html
  5. Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, AC Peter; Sherkey, Jeffrey A.; van de Sande, Marjorie I. (2003), "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols" (PDF), Journal of Chronic Fatigue Syndrome, 11 (2): 7–115, doi:10.1300/J092v11n01_02
  6. Lerner, AM; Ariza, ME; Williams, M; Jason, L; Beqaj, S; Fitzgerald, JT; Lemeshow, S; Glaser, R (2012), "Antibody to Epstein-Barr Virus Deoxyuridine Triphosphate Nucleotidohydrolase and Deoxyribonucleotide Polymerase in a Chronic Fatigue Syndrome Subset", PLoS ONE, 7 (11): e47891, doi:10.1371/journal.pone.0047891
  7. http://www.investinme.org/IIMEC3.shtml#agenda